Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

292
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
292
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

408
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
408
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

538
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
538
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

359
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
359
Hormonal Regulation01:33

Hormonal Regulation

33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Model for Clinician and Staff Education in the Engagement of American Indians in Genomic Research.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Perspectives on Contraceptive Research for Individuals with Increased Thrombosis Risk: A Qualitative Exploration of Patients and Clinicians.

Southern medical journal·2026
Same author

Low-Dose Buprenorphine Induction in Pregnant and Postpartum Patients: A Retrospective Analysis of Protocol Implementation.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Health Priorities and Intervention Preferences among Young Adult Cancer Survivors: A Mixed-Methods Study.

Journal of adolescent and young adult oncology·2026
Same author

Decline in Applicants to Obstetrics and Gynecology Fellowships: Influence on Match Rates and Competitiveness.

O&G open·2026
Same author

A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study.

Journal of medical Internet research·2026

Related Experiment Video

Updated: Jul 12, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

778

Implementation of pharmacy access to hormonal contraception.

Lindsay E Dale, Victoria Trujillo, Alexandra Herman

    Journal of the American Pharmacists Association : Japha
    |October 27, 2023
    PubMed
    Summary

    Pharmacists can now prescribe hormonal contraception in many states, improving access. Key implementation steps include developing clear rules, education, and reimbursement, with billing mechanisms being most critical for success.

    More Related Videos

    Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
    09:34

    Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

    Published on: February 9, 2019

    9.0K
    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
    08:20

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

    Published on: October 2, 2018

    11.3K

    Related Experiment Videos

    Last Updated: Jul 12, 2025

    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
    06:27

    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

    Published on: January 10, 2025

    778
    Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
    09:34

    Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

    Published on: February 9, 2019

    9.0K
    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
    08:20

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

    Published on: October 2, 2018

    11.3K

    Area of Science:

    • Public Health
    • Health Services Research
    • Pharmacy Practice

    Background:

    • States are increasingly authorizing pharmacists to prescribe hormonal contraception to reduce access barriers.
    • Understanding the state-level implementation of this policy is crucial for effective rollout.

    Purpose of the Study:

    • To identify state-level implementation steps for pharmacist prescribing of hormonal contraception.
    • To explore challenges and facilitators encountered during this process.

    Main Methods:

    • Qualitative study involving interviews with 18 key stakeholders across ten states.
    • Analysis using directed qualitative analysis and the Consolidated Framework for Implementation Research.

    Main Results:

    • Four key implementation steps were identified: rule development, education, reimbursement, and expansion.
    • Facilitators included stakeholder involvement and supportive pharmacy culture.
    • Challenges involved complex billing, funding, and competing priorities.

    Conclusions:

    • Developing robust reimbursement and billing mechanisms is the most critical step for states implementing pharmacist prescribing of hormonal contraception.
    • Focusing on facilitators can guide states in successful implementation to enhance contraceptive access.